ReviewIndian journal of ophthalmology2026
Consensus statement for the diagnosis and management of optic neuritis.
Review in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This consensus statement provides a practical, step-by-step framework designed by 19 national specialists to standardize the care of optic neuritis. Recognizing that clinicians handle these cases differently depending on local resources, the guidelines offer a clear roadmap for distinguishing true optic nerve inflammation from its common clinical mimics. The primary focus is on identifying early "red flags," optimizing neuroimaging protocols, and using targeted cell-based antibody testing to pinpoint the exact cause of the disease. Beyond immediate diagnosis, the paper outlines clear strategies for managing acute episodes with high-dose therapies, handling patients who do not respond to initial steroids, and establishing structured, long-term monitoring plans to track visual recovery. Because delayed or incorrect treatment can lead to permanent, irreversible nerve damage, this document serves as a reliable tool to help ophthalmologists make quick, safe, and effective clinical decisions for patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.